IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback